header advert
Results 1 - 1 of 1
Results per page:
Orthopaedic Proceedings
Vol. 97-B, Issue SUPP_16 | Pages 23 - 23
1 Dec 2015
Kursumovic K Charalambous C
Full Access

No consensus exists regarding the optimal graft choice between allogenic and autologous graft. Incidence of septic arthritis following ACL reconstruction is rare but may dependent on the graft type. Our meta-analysis assesses the difference in incidence of septic arthritis after ACL reconstruction across three groups of grafts: hamstring autografts, bone patellar tendon bone (BPTB) autografts and allografts of any type.

A literature search was performed without language restriction on PubMed and EMBASE databases. We identified 245 infected ACL grafts across 15 included studies that provided a breakdown of infection incidence by graft type. A meta-analysis was performed using a random-effects model to estimate the overall infection rates and those for different graft types. Summary risk ratios and 95% confidence intervals (CIs) were calculated and reported for each outcome. Publication bias with respect to infection rates was estimated using a funnel plot.

Our meta-analysis shows an overall ACL graft infection rate of 0.6% (CI 0.3% – 1.3%). The incidence was highest in autologous hamstring grafts at 1.1% at (CI 0.8% – 1.6%). That of allografts and autologous BPTB grafts was similar at 0.5% (CI 0.2%–1.0%) and 0.4% (CI 0.2% – 0.7%), respectively. Full breakdown of the meta-analysis results by study and graft type is reported in Figure 1.

Septic arthritis after ACL reconstruction remains a rare (<1%) but a serious complication. Allograft rates of infection were not higher than those the autografts, contrary to the theoretical concerns. Therefore a higher infection risk should not be cited as a reason for not using it. The reason for the apparently higher infection rate with hamstring autografts is unclear and requires further research. The results of our meta-analysis may aid informed discussions between surgeons and patients about the risk of infection after ACL reconstructive surgery and graft choice.